Overview
- 15 inspections across 15 sites are on record.
- 63 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-08.
At a glance
Inspections
15
Sites
15
Observations
63
Career since
Apr 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Perrigo New York, Inc. | 8 May 2026 | Human Drugs | On file |
| Tender Corporation D/B/A Adventure Ready Brands | 10 Apr 2026 | Human Drugs | On file |
| Lyne Laboratories, Inc. | 10 Mar 2026 | Human Drugs | On file |
| Vantage Specialty Ingredients, Inc. | 23 Jan 2026 | Human Drugs | On file |
| Ardena U.S. LLC | 21 Nov 2025 | Human Drugs |
Sites inspected
Perrigo New York, Inc.Bronx, United States1 insp.
Tender Corporation D/B/A Adventure Ready BrandsLittleton, United States1 insp.
Lyne Laboratories, Inc.Brockton, United States1 insp.
Vantage Specialty Ingredients, Inc.Fairfield, United States1 insp.
Ardena U.S. LLCSomerset, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Edmund F Mrak3 shared
Lori M Newman2 shared
Daniel L Zheng2 shared
Anthony J Donato2 shared
Tanya R Syffrard1 shared
Jonathan G Matrisciano1 shared
Christian F Gomez Lugo1 shared
Janet A Rajan1 shared
Erik W Koester1 shared
Elena N Thomas1 shared
Full investigator report
Get the verbatim findings behind Ifechimere I Okafor's 63 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site